Your browser doesn't support javascript.
loading
Istaroxime and Beyond: New Therapeutic Strategies to Specifically Activate SERCA and Treat Heart Failure.
Avvisato, Roberta; Jankauskas, Stanislovas S; Santulli, Gaetano.
Affiliation
  • Avvisato R; Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Aging Research (R.A., S.S.J., G.S.) and Department of Molecular Pharmacology, Institute for Neuroimmunology and Inflammation, Fleischer Institute for Diabetes and Metabolism (FIDAM) (G.S.), Albert Einstein College of Medicine, New York, New York.
  • Jankauskas SS; Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Aging Research (R.A., S.S.J., G.S.) and Department of Molecular Pharmacology, Institute for Neuroimmunology and Inflammation, Fleischer Institute for Diabetes and Metabolism (FIDAM) (G.S.), Albert Einstein College of Medicine, New York, New York.
  • Santulli G; Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Aging Research (R.A., S.S.J., G.S.) and Department of Molecular Pharmacology, Institute for Neuroimmunology and Inflammation, Fleischer Institute for Diabetes and Metabolism (FIDAM) (G.S.), Albert Einstein College of Medicine, New York, New York gsantulli001@gmail.com.
J Pharmacol Exp Ther ; 384(1): 227-230, 2023 01.
Article in En | MEDLINE | ID: mdl-36581352

Full text: 1 Database: MEDLINE Main subject: Heart Failure Limits: Humans Language: En Journal: J Pharmacol Exp Ther Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Heart Failure Limits: Humans Language: En Journal: J Pharmacol Exp Ther Year: 2023 Type: Article